247 related articles for article (PubMed ID: 37407817)
1. Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotide.
Sherwood AV; Rivera-Rangel LR; Ryberg LA; Larsen HS; Anker KM; Costa R; Vågbø CB; Jakljevič E; Pham LV; Fernandez-Antunez C; Indrisiunaite G; Podolska-Charlery A; Grothen JER; Langvad NW; Fossat N; Offersgaard A; Al-Chaer A; Nielsen L; Kuśnierczyk A; Sølund C; Weis N; Gottwein JM; Holmbeck K; Bottaro S; Ramirez S; Bukh J; Scheel TKH; Vinther J
Nature; 2023 Jul; 619(7971):811-818. PubMed ID: 37407817
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
Saito T; Owen DM; Jiang F; Marcotrigiano J; Gale M
Nature; 2008 Jul; 454(7203):523-7. PubMed ID: 18548002
[TBL] [Abstract][Full Text] [Related]
3. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
4. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.
Schnell G; Loo YM; Marcotrigiano J; Gale M
PLoS Pathog; 2012; 8(8):e1002839. PubMed ID: 22912574
[TBL] [Abstract][Full Text] [Related]
5. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
6. A gel electrophoresis-based assay for measuring enzymatic RNA decapping activity.
Singh Y; Bird JG
Methods Enzymol; 2022; 675():323-350. PubMed ID: 36220275
[TBL] [Abstract][Full Text] [Related]
7. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.
Paul D; Hoppe S; Saher G; Krijnse-Locker J; Bartenschlager R
J Virol; 2013 Oct; 87(19):10612-27. PubMed ID: 23885072
[TBL] [Abstract][Full Text] [Related]
8. USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.
Kusakabe S; Suzuki T; Sugiyama Y; Haga S; Horike K; Tokunaga M; Hirano J; Zhang H; Chen DV; Ishiga H; Komoda Y; Ono C; Fukuhara T; Yamamoto M; Ikawa M; Satoh T; Akira S; Tanaka T; Moriishi K; Fukai M; Taketomi A; Yoshio S; Kanto T; Suzuki T; Okamoto T; Matsuura Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626683
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus RNA translation.
Niepmann M
Curr Top Microbiol Immunol; 2013; 369():143-66. PubMed ID: 23463200
[TBL] [Abstract][Full Text] [Related]
10. Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome.
Komurian-Pradel F; Perret M; Deiman B; Sodoyer M; Lotteau V; Paranhos-Baccalà G; André P
J Virol Methods; 2004 Mar; 116(1):103-6. PubMed ID: 14715313
[TBL] [Abstract][Full Text] [Related]
11. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.
Tsutsumi M; Urashima S; Takada A; Date T; Tanaka Y
Hepatology; 1994 Feb; 19(2):265-72. PubMed ID: 7507461
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA.
Takeda S; Shibata M; Morishima T; Harada A; Nakao A; Takagi H; Nagai Y
Cancer; 1992 Nov; 70(9):2255-9. PubMed ID: 1327494
[TBL] [Abstract][Full Text] [Related]
13. Captivating Perplexities of
Kniert J; Lin QF; Shmulevitz M
Viruses; 2021 Feb; 13(2):. PubMed ID: 33668598
[TBL] [Abstract][Full Text] [Related]
14. Noncanonical RNA-capping: Discovery, mechanism, and physiological role debate.
Julius C; Yuzenkova Y
Wiley Interdiscip Rev RNA; 2019 Mar; 10(2):e1512. PubMed ID: 30353673
[TBL] [Abstract][Full Text] [Related]
15. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
16. In vitro models for analysis of the hepatitis C virus life cycle.
Aly HH; Shimotohno K; Hijikata M; Seya T
Microbiol Immunol; 2012 Jan; 56(1):1-9. PubMed ID: 22145950
[TBL] [Abstract][Full Text] [Related]
17. Capping of vesicular stomatitis virus pre-mRNA is required for accurate selection of transcription stop-start sites and virus propagation.
Ogino T
Nucleic Acids Res; 2014 Oct; 42(19):12112-25. PubMed ID: 25274740
[TBL] [Abstract][Full Text] [Related]
18. A cell-based model of HCV-negative-strand RNA replication utilizing a chimeric hepatitis C virus/reporter RNA template.
King RW; Zecher M; Jeffries MW; Carroll DR; Parisi JM; Pasquinelli C
Antivir Chem Chemother; 2002 Nov; 13(6):353-62. PubMed ID: 12718407
[TBL] [Abstract][Full Text] [Related]
19. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
20. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells.
Mellor J; Haydon G; Blair C; Livingstone W; Simmonds P
J Gen Virol; 1998 Apr; 79 ( Pt 4)():705-14. PubMed ID: 9568964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
